Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,960 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.
Beck RW, Trobe JD, Moke PS, Gal RL, Xing D, Bhatti MT, Brodsky MC, Buckley EG, Chrousos GA, Corbett J, Eggenberger E, Goodwin JA, Katz B, Kaufman DI, Keltner JL, Kupersmith MJ, Miller NR, Nazarian S, Orengo-Nania S, Savino PJ, Shults WT, Smith CH, Wall M; Optic Neuritis Study Group. Beck RW, et al. Among authors: wall m. Arch Ophthalmol. 2003 Jul;121(7):944-9. doi: 10.1001/archopht.121.7.944. Arch Ophthalmol. 2003. PMID: 12860795 Clinical Trial.
Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial.
Beck RW, Gal RL, Bhatti MT, Brodsky MC, Buckley EG, Chrousos GA, Corbett J, Eggenberger E, Goodwin JA, Katz B, Kaufman DI, Keltner JL, Kupersmith MJ, Miller NR, Moke PS, Nazarian S, Orengo-Nania S, Savino PJ, Shults WT, Smith CH, Trobe JD, Wall M, Xing D; Optic Neuritis Study Group. Beck RW, et al. Among authors: wall m. Am J Ophthalmol. 2004 Jan;137(1):77-83. doi: 10.1016/s0002-9394(03)00862-6. Am J Ophthalmol. 2004. PMID: 14700647 Clinical Trial.
Neurologic impairment 10 years after optic neuritis.
Beck RW, Smith CH, Gal RL, Xing D, Bhatti MT, Brodsky MC, Buckley EG, Chrousos GA, Corbett J, Eggenberger E, Goodwin JA, Katz B, Kaufman DI, Keltner JL, Kupersmith MJ, Miller NR, Moke PS, Nazarian S, Orengo-Nania S, Savino PJ, Shults WT, Trobe JD, Wall M; Optic Neuritis Study Group. Beck RW, et al. Among authors: wall m. Arch Neurol. 2004 Sep;61(9):1386-9. doi: 10.1001/archneur.61.9.1386. Arch Neurol. 2004. PMID: 15364684
The Neuro-Ophthalmology Research Disease Investigator Consortium (NORDIC).
Kupersmith MJ, Miller N, Balcer L, Gordon L, Wall M, Keltner J, Friedman D, Feldon S, McDermott M, Kieburtz K. Kupersmith MJ, et al. Among authors: wall m. J Neuroophthalmol. 2009 Sep;29(3):259-61. doi: 10.1097/WNO.0b013e3181b1481c. J Neuroophthalmol. 2009. PMID: 19726952 No abstract available.
Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.
NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee; Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, Kupersmith MJ. NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, et al. Among authors: wall m. JAMA. 2014 Apr 23-30;311(16):1641-51. doi: 10.1001/jama.2014.3312. JAMA. 2014. PMID: 24756514 Free PMC article. Clinical Trial.
Idiopathic intracranial hypertension--reply.
Wall M, McDermott M, Kupersmith M. Wall M, et al. JAMA. 2014 Sep 10;312(10):1060. doi: 10.1001/jama.2014.8903. JAMA. 2014. PMID: 25203092 No abstract available.
Treating idiopathic intracranial hypertension--reply.
Wall M, McDermott MP, Kieburtz KD, Kupersmith MJ. Wall M, et al. JAMA Neurol. 2014 Oct;71(10):1327-8. doi: 10.1001/jamaneurol.2014.2363. JAMA Neurol. 2014. PMID: 25322318 No abstract available.
1,960 results